Müller-Tidow C - Search Results

1

Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.

Liebers N, Bruch PM, Terzer T, Hernandez-Hernandez M, Paramasivam N, Fitzgerald D, Altmann H, Roider T, Kolb C, Knoll M, Lenze A, Platzbecker U, Röllig C, Baldus C, Serve H, Bornhäuser M, Hübschmann D, Müller-Tidow C, Stölzel F, Huber W, Benner A, Zenz T, Lu J, Dietrich S. Liebers N, et al. Nat Cancer. 2023 Dec;4(12):1648-1659. doi: 10.1038/s43018-023-00645-5. Epub 2023 Oct 2. Nat Cancer. 2023. PMID: 37783805 Free PMC article.

2

Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.

Müller-Tidow C, Kügler K, Diederichs S, Klümpen S, Möller M, Vogt U, Metzger R, Schneider PM, Berdel WE, Serve H. Müller-Tidow C, et al. Br J Cancer. 2001 Oct 19;85(8):1168-74. doi: 10.1054/bjoc.2001.2041. Br J Cancer. 2001. PMID: 11710831 Free PMC article.

3

Cyclin A1 is highly expressed in aggressive testicular germ cell tumors.

Müller-Tidow C, Diederichs S, Schrader MG, Vogt U, Miller K, Berdel WE, Serve H. Müller-Tidow C, et al. Cancer Lett. 2003 Feb 10;190(1):89-95. doi: 10.1016/s0304-3835(02)00582-7. Cancer Lett. 2003. PMID: 12536081

4

Specific protein redirection as a transcriptional therapy approach for t(8;21) leukemia.

Steffen B, Serve H, Berdel WE, Agrawal S, Linggi B, Büchner T, Hiebert SW, Müller-Tidow C. Steffen B, et al. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8448-53. doi: 10.1073/pnas.1330293100. Epub 2003 Jun 20. Proc Natl Acad Sci U S A. 2003. PMID: 12819347 Free PMC article.

5

Redirection of oncoproteins to kill cancer cells.

Müller-Tidow C, Steffen B, Berdel WE, Serve H. Müller-Tidow C, et al. Cell Cycle. 2003 Nov-Dec;2(6):531-3. doi: 10.4161/cc.2.6.585. Cell Cycle. 2003. PMID: 14504468 Review.

6

E- and A-type cyclins as markers for cancer diagnosis and prognosis.

Yasmeen A, Berdel WE, Serve H, Müller-Tidow C. Yasmeen A, et al. Expert Rev Mol Diagn. 2003 Sep;3(5):617-33. doi: 10.1586/14737159.3.5.617. Expert Rev Mol Diagn. 2003. PMID: 14510182 Review.

7

Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia.

Tiesmeier J, Czwalinna A, Müller-Tidow C, Krauter J, Serve H, Heil G, Ganser A, Verbeek W. Tiesmeier J, et al. Br J Haematol. 2003 Nov;123(3):413-9. doi: 10.1046/j.1365-2141.2003.04618.x. Br J Haematol. 2003. PMID: 14616999 Free article.

8

S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.

Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, Lang K, Zänker KS, Metzger R, Schneider PM, Gerke V, Thomas M, Berdel WE, Serve H, Müller-Tidow C. Diederichs S, et al. Cancer Res. 2004 Aug 15;64(16):5564-9. doi: 10.1158/0008-5472.CAN-04-2004. Cancer Res. 2004. PMID: 15313892

9

Genome-wide screening for prognosis-predicting genes in early-stage non-small-cell lung cancer.

Müller-Tidow C, Diederichs S, Thomas M, Serve H. Müller-Tidow C, et al. Lung Cancer. 2004 Aug;45 Suppl 2:S145-50. doi: 10.1016/j.lungcan.2004.07.979. Lung Cancer. 2004. PMID: 15552795 Review.

10

In vivo analyses of UV-irradiation-induced p53 promoter binding using a novel quantitative real-time PCR assay.

Potratz JC, Mlody B, Berdel WE, Serve H, Müller-Tidow C. Potratz JC, et al. Int J Oncol. 2005 Feb;26(2):493-8. Int J Oncol. 2005. PMID: 15645135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

506 results

Search Page